FDA Denies Adial Pharma’s Fast Track Request For AD04 in Alcohol Use Disorder
Adial Pharmaceuticals Inc (NASDAQ:ADIL) has received notice from the FDA that its request for Fast Track Designation for AD04…
The Daily Biotech Pulse: Roche Gets Authorization For COVID-19 Treatment, Nods For Sanofi-Regeneron In Europe, Osmotica Divestment, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 24)
45 Biggest Movers From Yesterday
Gainers
Marin Software Incorporated (NASDAQ: MRIN) shares surged 105.3% to close at $3.51 on Thursday after the company announced it has added the ability to manage Instacart Ads to its flagship MarinOne platform.
Adial Pharmaceuticals Provides Regulatory And Development Update; Says Has Announced It Received Correspondence Related To Request For Fast Track Designation From FDA; Says Request Was Denied By FDA
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL, ADILW)))), a clinical-stage biopharmaceutical company focused on the development of treatments for addictions, today announced that it has received correspondence related to its
36 Stocks Moving In Thursday’s Mid-Day Session
Gainers
Marin Software Incorporated (NASDAQ: MRIN) jumped 58% to $2.70 after the company announced it has added the ability to manage Instacart Ads to its flagship MarinOne platform.
45 Biggest Movers From Yesterday
Gainers
Entera Bio Ltd. (NASDAQ: ENTX) shares surged 44.8% to close at $6.50 on Wednesday after the company reported topline Phase 2 bone mineral density data for EB613.
31 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Entera Bio Ltd. (NASDAQ: ENTX) shares jumped 58% to $7.09 after the company reported topline Phase 2 bone mineral density data for EB613.